Back to top
more

MannKind (MNKD)

(Delayed Data from NSDQ)

$5.82 USD

5.82
2,248,262

-0.07 (-1.19%)

Updated Jul 24, 2024 04:00 PM ET

After-Market: $5.82 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for MNKD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for MannKind Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 295 171 204 67 50
Receivables 15 17 5 4 4
Notes Receivable 0 0 0 0 0
Inventories 29 22 7 5 4
Other Current Assets 35 25 3 3 3
Total Current Assets 373 235 220 79 61
Net Property & Equipment 84 45 37 26 27
Investments & Advances 7 2 57 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 3 4 0 0 0
Deposits & Other Assets 7 10 8 3 6
Total Assets 475 295 321 109 94
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 5
Accounts Payable 10 11 7 6 5
Current Portion Long-Term Debt 10 10 7 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 42 36 27 20 16
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 43 11 7 48 40
Total Current Liabilities 104 67 48 74 66
Mortgages 0 0 0 0 0
Deferred Taxes/Income 70 0 20 0 8
Convertible Debt 227 225 224 5 5
Long-Term Debt 116 103 151 113 109
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 201 82 87 96 94
Minority Interest (Liabilities) 0 63 0 0 0
Total Liabilities 721 546 531 289 284
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 2 2
Capital Surplus 2,981 2,964 2,918 2,866 2,799
Retained Earnings -3,229 -3,217 -3,130 -3,049 -2,992
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -246 -251 -209 -180 -191
Total Liabilities & Shareholder's Equity 475 295 321 109 94
Total Common Equity -246 -251 -209 -180 -191
Shares Outstanding 269.50 263.20 251.40 232.60 206.40
Book Value Per Share -0.91 -0.95 -0.83 -0.78 -0.92

Fiscal Year End for MannKind Corporation falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 301 295 141 144
Receivables NA 20 15 22 28
Notes Receivable NA 0 0 0 0
Inventories NA 26 29 27 25
Other Current Assets NA 36 35 36 33
Total Current Assets NA 383 373 226 230
Net Property & Equipment NA 84 84 80 70
Investments & Advances NA 4 7 3 2
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 3 3 3 3
Deposits & Other Assets NA 7 7 8 8
Total Assets NA 481 475 320 313
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 7 10 17 17
Current Portion Long-Term Debt NA 30 10 30 10
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 42 42 32 37
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 21 43 18 33
Total Current Liabilities NA 100 104 96 97
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 68 70 69 0
Convertible Debt NA 227 227 226 226
Long-Term Debt NA 111 116 121 103
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 201 54 143
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 711 721 572 574
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 3 3 3 3
Capital Surplus NA 2,986 2,981 2,976 2,969
Retained Earnings NA -3,219 -3,229 -3,231 -3,233
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA -230 -246 -252 -260
Total Liabilities & Shareholder's Equity NA 481 475 320 313
Total Common Equity 0 -230 -246 -252 -260
Shares Outstanding 272.30 272.30 269.50 269.50 268.30
Book Value Per Share 0.00 -0.84 -0.91 -0.93 -0.97